X4 PHARMACEUTICALS INC (XFOR)

US98420X1037 - Common Stock

1.15  +0.07 (+6.48%)

After market: 1.13 -0.02 (-1.74%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.003.00M0.00
Operating Expenses
107.52M88.08M75.35M62.88M46.80M
Research and Development
72.02M61.06M50.65M41.93M30.16M
Selling, General, and Administrative Expenses
35.51M27.02M24.70M20.94M16.64M
Operating Income
-107.52M-88.08M-75.35M-59.88M-46.80M
Interest Income/Expense
5.88M-2.07M-4.00M-2.85M-770.00K
Other Income/Expense
554.00K-4.20M430.00K910.00K230.00K
Non Recurring Items
0.00510.00K-9.76M-160.00K-5.47M
Income Before Taxes
-101.09M-93.84M-88.68M-61.98M-52.81M
Income Tax
78.00K30.00K20.00K150.00KN/A
Net Income
-101.17M-96.41M-102.64M-62.13M-53.40M
EBITDA
-107.10M-87.57M-74.85M-59.53M-46.70M
 
Per Share Data
EPS Diluted Total Ops
-0.57-1.52-3.99-3.09-4.63
Non GAAP EPS
-0.60-1.87-3.70-2.97N/A
 
Statistics
Profit Margin
N/AN/AN/A-2071.00%N/A
Operating Profit Margin
N/AN/AN/A-1996.00%N/A

All data in USD

Charts